Literature DB >> 15509773

NCR-1 and NCR-2, the C. elegans homologs of the human Niemann-Pick type C1 disease protein, function upstream of DAF-9 in the dauer formation pathways.

Jie Li1, Gemma Brown, Michael Ailion, Samuel Lee, James H Thomas.   

Abstract

Mutations in the human NPC1 gene cause most cases of Niemann-Pick type C (NP-C) disease, a fatal autosomal recessive neurodegenerative disorder. NPC1 is implicated in intracellular trafficking of cholesterol and glycolipids, but its exact function remains unclear. The C. elegans genome contains two homologs of NPC1, ncr-1 and ncr-2, and an ncr-2; ncr-1 double deletion mutant forms dauer larvae constitutively (Daf-c). We have analyzed the phenotypes of ncr single and double mutants in detail, and determined the ncr gene expression patterns. We find that the ncr genes function in a hormonal branch of the dauer formation pathway upstream of daf-9 and daf-12, which encode a cytochrome P450 enzyme and a nuclear hormone receptor, respectively. ncr-1 is expressed broadly in tissues with high levels of cholesterol, whereas expression of ncr-2 is restricted to a few cells. Both Ncr genes are expressed in the XXX cells, which are implicated in regulating dauer formation via the daf-9 pathway. Only the ncr-1 mutant is hypersensitive to cholesterol deprivation and to progesterone, an inhibitor of intracellular cholesterol trafficking. Our results support the hypothesis that ncr-1 and ncr-2 are involved in intracellular cholesterol processing in C. elegans, and that a sterol-signaling defect is responsible for the Daf-c phenotype of the ncr-2; ncr-1 mutant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509773     DOI: 10.1242/dev.01408

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  32 in total

Review 1.  Starvation Responses Throughout the Caenorhabditis elegans Life Cycle.

Authors:  L Ryan Baugh; Patrick J Hu
Journal:  Genetics       Date:  2020-12       Impact factor: 4.562

2.  A potential biochemical mechanism underlying the influence of sterol deprivation stress on Caenorhabditis elegans longevity.

Authors:  Mi Cheong Cheong; Keun Na; Heekyeong Kim; Seul-Ki Jeong; Hyoe-Jin Joo; David J Chitwood; Young-Ki Paik
Journal:  J Biol Chem       Date:  2010-12-24       Impact factor: 5.157

Review 3.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

Review 4.  Molting in C. elegans.

Authors:  Vladimir Lažetić; David S Fay
Journal:  Worm       Date:  2017-05-17

5.  Regulation of membrane trafficking by a novel Cdc42-related protein in Caenorhabditis elegans epithelial cells.

Authors:  S Jenna; M-E Caruso; A Emadali; D T Nguyên; M Dominguez; S Li; R Roy; J Reboul; M Vidal; G N Tzimas; R Bossé; E Chevet
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

Review 6.  Invertebrate models of lysosomal storage disease: what have we learned so far?

Authors:  Samantha Hindle; Sarita Hebbar; Sean T Sweeney
Journal:  Invert Neurosci       Date:  2011-10-25

7.  Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects.

Authors:  Megan L Fluegel; Tracey J Parker; Leo J Pallanck
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

8.  NSBP-1 mediates the effects of cholesterol on insulin/IGF-1 signaling in Caenorhabditis elegans.

Authors:  Mi Cheong Cheong; Hyoung-Joo Lee; Keun Na; Hyoe-Jin Joo; Leon Avery; Young-Jai You; Young-Ki Paik
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

9.  MLT-10 defines a family of DUF644 and proline-rich repeat proteins involved in the molting cycle of Caenorhabditis elegans.

Authors:  Vijaykumar S Meli; Beatriz Osuna; Gary Ruvkun; Alison R Frand
Journal:  Mol Biol Cell       Date:  2010-03-24       Impact factor: 4.138

Review 10.  C. elegans dauer formation and the molecular basis of plasticity.

Authors:  Nicole Fielenbach; Adam Antebi
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.